Cargando…
Exon-Skipping Strategy by Ratio Modulation between Cytoprotective versus Pro-Apoptotic Clusterin Forms Increased Sensitivity of LNCaP to Cell Death
BACKGROUND: In prostate cancer the secreted form of clusterin (sCLU) has been described as an anti-apoptotic protein whose expression is increased after therapeutic intervention, whereas, the nuclear protein form nCLU was reported to have pro-apoptotic properties. METHODOLOGY: In order to provide ne...
Autores principales: | Essabbani, Abdellatif, Garcia, Luis, Zonetti, Maria Josè, Fisco, Tommaso, Pucci, Sabina, Chiocchia, Gilles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572101/ https://www.ncbi.nlm.nih.gov/pubmed/23418433 http://dx.doi.org/10.1371/journal.pone.0054920 |
Ejemplares similares
-
ADAMTS1 alters blood vessel morphology and TSP1 levels in LNCaP and LNCaP-19 prostate tumors
por: Gustavsson, Heléne, et al.
Publicado: (2010) -
Clusterin exerts a cytoprotective and antioxidant effect in human osteoarthritic cartilage
por: Tarquini, Chiara, et al.
Publicado: (2020) -
Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo
por: ZHANG, XIANQING, et al.
Publicado: (2014) -
Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo
por: Zhang, Xianqing, et al.
Publicado: (2018) -
ARP2, a Novel Pro-Apoptotic Protein Expressed in Epithelial Prostate Cancer LNCaP Cells and Epithelial Ovary CHO Transformed Cells
por: Mas-Oliva, Jaime, et al.
Publicado: (2014)